IANNUZZO, GABRIELLA
 Distribuzione geografica
Continente #
AS - Asia 5.640
NA - Nord America 4.131
EU - Europa 3.764
SA - Sud America 712
AF - Africa 138
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 1
Totale 14.391
Nazione #
US - Stati Uniti d'America 3.947
SG - Singapore 2.474
RU - Federazione Russa 1.728
CN - Cina 1.089
VN - Vietnam 1.073
IT - Italia 819
BR - Brasile 547
HK - Hong Kong 365
DE - Germania 348
FR - Francia 231
FI - Finlandia 143
NL - Olanda 132
BD - Bangladesh 125
GB - Regno Unito 100
JP - Giappone 96
IN - India 88
CA - Canada 85
AR - Argentina 65
KR - Corea 58
MX - Messico 56
IE - Irlanda 45
CI - Costa d'Avorio 44
TH - Thailandia 44
PH - Filippine 37
PL - Polonia 37
ZA - Sudafrica 35
UA - Ucraina 33
AT - Austria 29
SE - Svezia 29
ID - Indonesia 27
EC - Ecuador 26
IQ - Iraq 26
ES - Italia 22
VE - Venezuela 19
TR - Turchia 18
PK - Pakistan 15
CL - Cile 14
CH - Svizzera 13
CO - Colombia 13
TW - Taiwan 12
MA - Marocco 11
NP - Nepal 10
PY - Paraguay 10
AE - Emirati Arabi Uniti 9
KE - Kenya 9
LT - Lituania 9
SA - Arabia Saudita 9
JO - Giordania 8
MY - Malesia 8
UZ - Uzbekistan 8
BE - Belgio 7
DZ - Algeria 7
EG - Egitto 7
NI - Nicaragua 7
BO - Bolivia 6
CR - Costa Rica 6
IL - Israele 6
IR - Iran 6
JM - Giamaica 6
PE - Perù 6
PT - Portogallo 6
UY - Uruguay 6
AL - Albania 5
BG - Bulgaria 5
CZ - Repubblica Ceca 5
HN - Honduras 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
GE - Georgia 3
GR - Grecia 3
GT - Guatemala 3
LB - Libano 3
OM - Oman 3
PS - Palestinian Territory 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
BB - Barbados 2
BS - Bahamas 2
CG - Congo 2
CM - Camerun 2
CY - Cipro 2
EE - Estonia 2
ET - Etiopia 2
GH - Ghana 2
HU - Ungheria 2
KH - Cambogia 2
KZ - Kazakistan 2
LC - Santa Lucia 2
LY - Libia 2
MK - Macedonia 2
RO - Romania 2
SC - Seychelles 2
SN - Senegal 2
AM - Armenia 1
AU - Australia 1
BF - Burkina Faso 1
BH - Bahrain 1
BJ - Benin 1
Totale 14.367
Città #
Singapore 1.232
San Jose 729
Ashburn 419
Moscow 372
Hong Kong 354
Ho Chi Minh City 349
Chandler 309
Beijing 305
Hefei 263
Hanoi 231
Santa Clara 197
Naples 151
Munich 141
Lauterbourg 121
Los Angeles 120
Millbury 90
The Dalles 78
Boardman 75
Helsinki 75
Tokyo 75
Amsterdam 72
Boston 68
Buffalo 64
New York 58
Napoli 55
Rome 52
São Paulo 51
Lawrence 49
Des Moines 44
Princeton 43
Seoul 42
Haiphong 40
Council Bluffs 39
Redondo Beach 39
Frankfurt am Main 38
Da Nang 37
Dallas 34
Orem 31
Nanjing 30
Toronto 29
Milan 28
Turku 27
Dong Ket 26
Nuremberg 26
Wilmington 24
Rio de Janeiro 23
Warsaw 23
Jacksonville 22
Seattle 22
Mexico City 21
Denver 20
Montreal 20
Phoenix 20
Atlanta 19
Bangkok 19
Dublin 19
Falkenstein 18
Houston 18
Shanghai 18
Biên Hòa 17
Brooklyn 17
Chennai 17
Chicago 16
London 16
Marsala 16
Washington 16
Changsha 15
Hebei 15
Stockholm 15
Brasília 14
Nanchang 14
San Francisco 14
Charlotte 13
Curitiba 13
Düsseldorf 13
Fairfield 13
Jiaxing 13
Krefeld 13
Ottawa 13
Bologna 12
Guangzhou 12
Hải Dương 12
Xi'an 12
Johannesburg 11
Manchester 11
Poplar 11
Quận Bình Thạnh 11
Vienna 11
Woodbridge 11
Augusta 10
Baghdad 10
Bar Harbor 10
Genoa 10
Portsmouth 10
Thái Bình 10
Buenos Aires 9
Can Tho 9
Dhaka 9
Guayaquil 9
Lappeenranta 9
Totale 7.526
Nome #
Short-term treatment of iron deficiency anemia after cardiac surgery 272
Efficacy, safety, adherence and persistence of PCSK9 inhibitors in clinical practice: A single country, multicenter, observational study (AT-TARGET-IT) 262
Dyslipidemia in Transplant Patients: Which Therapy? 210
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia 169
Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide Study 164
Efficacy and safety of lomitapide in homozygous familial hypercholesterolaemia: the pan-European retrospective observational study 163
A wide next-generation-sequencing panel improves the molecular diagnosis of dyslipidemias 154
Apo B, Small-dense LDL and carotid atherosclerosis in menopausal women 153
Atherogenic Lipoprotein Subfractions and Carotid Atherosclerosis in Menopausal Women 153
Genetic spectrum of familial hypercholesterolemia and correlations with clinical expression: Implications for diagnosis improvement 150
Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia: Systematic Review and Meta-Analysis of Randomized Controlled Trials 149
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia 148
Association between small dense LDL and sub-clinical atherosclerosis in patients with psoriatic arthritis 147
Association between small dense LDL and early atherosclerosis in a sample of menopausal women. 143
Association between causative mutations and response to PCSK9 inhibitor therapy in subjects with familial hypercholesterolemia: A single center real-world study 141
Association between small dense LDL particles and early atherosclerosis in a sample of middle-aged women. Findings from Progetto Atena 140
Effects of Bisphosphonate Treatment on Circulating Lipid and Glucose Levels in Patients with Metabolic Bone Disorders 140
Lipoprotein(A) where do we stand? from the physiopathology to innovative terapy 138
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia 138
Efficacy and safety of lomitapide in familial chylomicronaemia syndrome 136
Association of apolipoprotein levels with peripheral arterial disease: a meta-analysis of literature studies 134
Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia 133
Predictive and prognostic markers in a cohort of Mediterranean women:review from Atena project 133
Inhibitors of Protein Convertase Subtilisin/Kexin 9 (PCSK9) and Acute Coronary Syndrome (ACS): The State-of-the-Art 132
Carotid Atherosclerosis, Ultrasound and Lipoproteins 131
Association between Non-HDL-C/HDL-C Ratio and Carotid Intima-Media Thickness in Post-Menopausal Women. 131
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features. 131
Case Report: Genetic Analysis of PEG-Asparaginase Induced Severe Hypertriglyceridemia in an Adult With Acute Lymphoblastic Leukaemia 130
Impact of 12-SNP and 6-SNP Polygenic Scores on Predisposition to High LDL-Cholesterol Levels in Patients with Familial Hypercholesterolemia 129
Association between Very Low-Density Lipoprotein Cholesterol (VLDL-C) and Carotid Intima-Media Thickness in Postmenopausal Women Without Overt Cardiovascular Disease and on LDL-C Target Levels. 129
New Ultrasound Technologies for Ischemic Heart Disease Assessment and Monitoring in Cardiac Rehabilitation 129
New insights into the management of homozygous familial hypercholesterolemia patients treated with lomitapide: a single-center experience 129
Evinacumab for Homozygous Familial Hypercholesterolemia: The Italian Cohort of the ELIPSE HoFH Study 127
Aterosclerosi preclinica 127
Frailty in Acute and Chronic Coronary Syndrome Patients Entering Cardiac Rehabilitation 127
The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group 126
Effects of weight modification on hs-crp in a cohort of mediterranean women: findings from progetto atena. 126
A Real-World Experience of Clinical, Biochemical and Genetic Assessment of Patients with Homozygous Familial Hypercholesterolemia 126
Screening for Familial Combined Hyperlipidemia criteria in a cohort of Mediterranean women: findings from Progetto ATENA 125
Renal involvement in COVID-19: focus on kidney transplant sector 125
Iodine Requirements in Pediatrics: From Fetal Life to Adolescence 123
More inflammation in Familial Hypercholesterolemia than in Familial Combined Hyperlipidemia. 123
Association of systemic lupus erythematosus with peripheral arterial disease: a meta-analysis of literature studies 123
Sex-related differences in response to lomitapide in HoFH: A subanalysis of the Pan-European Lomitapide retrospective observational study 122
Efficacy and safety of direct oral anticoagulants in splanchnic vein thrombosis: a pooled analysis of literature studies 122
Creatinine levels and intima media thickness in a population based cohort study: finding from Progetto Atena. 122
Association between Lp (a) and atherosclerosis in menopausal women without metabolic syndrome. 122
Changes in carotid stiffness in patients with familial hypercholesterolemia treated with Evolocumab®: A prospective cohort study 122
Authors’ response to letter by Sbrana et al. “Evolocumab improve intima media thickness regression in He-FH subjects on lipoprotein apheresis” 122
A height-weight formula to measure body fat in childhood obesity 121
Inflammatory markers in Familial Combined Hyperlipidemia 121
Impaired endothelium-dependent vascular reactivity in patients with familial combined hyperlipidaemia. 120
Association between body shape index and small dense LDL particles in a cohort of mediterranean women: Findings from Progetto ATENA 120
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry 120
Cardiovascular disease and antiphospholipid syndrome: how to predict and how to treat? 118
Fat mass and vascular health in overweight/obese children 118
Exercise Training in Patients with Heart Failure: From Pathophysiology to Exercise Prescription 118
Venous thromboembolism and major bleeding in severe and critical COVID-19 hospitalized patients 118
Endothelial function improvement in patients with familial hypercholesterolemia receiving PCSK-9 inhibitors on top of maximally tolerated lipid lowering therapy 117
Changes in markers of subclinical atherosclerosis in patients with familial hypercholesterolemia treated with evolocumab: a prospective cohort study 116
Assessment of Platelet Aggregation and Thrombin Generation in Patients with Familial Chylomicronemia Syndrome Treated with Volanesorsen: A Cross-Sectional Study 116
SMALL DENSE LDL IN RELATION TO CHANGES IN OXIDATION MARKERS AND VASCULAR REACTIVITYIN PATIENTS WITH HYPERCHOLESTEROLEMIA TREATED WITH EVOLOCUMAB: A PROSPECTIVE COHORT STUDY 116
Biochemical Screening for Familial Combined Hyperlipidemia 115
Exercise Training in Elderly Cancer Patients: A Systematic Review 114
ipotiroidismo subclinico ed aterosclerosi carotidea 114
EVOLOCUMAB IS EFFECTIVE AND SAFE TO TREAT HYPERCHOLESTEROLEMIA IN A PATIENT WITH STATIN-INDUCED NECROTIZING MYOPATHY 114
Evinacumab for Homozygous Familial Hypercholesterolemia 114
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study 113
Association between small dense ldl and cardiovascular events in Familial combined hyperlipidemia. 113
Familial Combined hyperlipidemia and IMT 113
Idiopathic Osteoporosis and Nephrolithiasis: Two Sides of the Same Coin? 113
The bone-heart axis in the pathogenesis of cardiovascular diseases: A narrative review 112
Pathophysiological Role of Synovitis in Hemophilic Arthropathy Development: A Two-Hit Hypothesis 112
Sacubitril/Valsartan Improves Autonomic Function and Cardiopulmonary Parameters in Patients with Heart Failure with Reduced Ejection Fraction 112
Twelve Variants Polygenic Score for Low-Density Lipoprotein Cholesterol Distribution in a Large Cohort of Patients With Clinically Diagnosed Familial Hypercholesterolemia With or Without Causative Mutations 112
Tumor Necrosis Factor-α is a marker of Familial Conbined Hyperlipidemia, independently of metabolic sindrome 111
Association between Lp(a) and small dense LDL in menopausal women without metabolic syndrome 111
Efficacy and safety of lipid-lowering therapies in combination with or without statin to reduce the cardiovascular risk: A systematic review of randomised controlled trials 108
Tumor necrosis factor-α is a marker of familial combined hyperlipidemia, independently of metabolic syndrome 108
Early carotid atherosclerosis in obesity and overweight is independent of hs-CRP in a cohort of mediterranean women: findings from Progetto Atena 108
Società per lo studio dell'aterosclerosi ( Sezione Campania) 107
Clinical Evidence for Q10 Coenzyme Supplementation in Heart Failure: From Energetics to Functional Improvement 107
Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey 107
The relationship between BMI and common carotid plaques or Apo B and bifurcation plaques are independent of hs-CPR concentration: findings from Progetto ATENA 105
Effects of short-term reduction in serum cholesterol with simvastatin in patients with stable angina pectoris and mild to moderate hypercholesterolemia 105
Oltre le statine quale terapia per l'ipercolesterolemia: gli inibitori del pCSK9 e l'inclisiran 105
[How to overcome barriers to implementation of prevention and management strategies of atherosclerotic cardiovascular disease through lipid-lowering therapy] 104
Relation of body mass index with carotid intima-media thickness and diameter is independent of metabolic syndrome in postmenopausal Mediterranean women. 104
Lipoprotein (a) is an independent predictor of cardiovascular events in Mediterranean women (Progetto Atena) 104
Small dense low-density lipoprotein in familial combined hyperlipidemia: Independent of metabolic syndrome and related to history of cardiovascular events. 104
High endogenous estradiol is associated with increased venous distensibility and clinical evidence of varicose veins in menopausal women. 102
Carotid artery wall hypertrophy in children with metabolic syndrome 101
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Use for Atherogenic Dyslipidemia in Solid Organ Transplant Patients 101
Relation of body mass index with intima media thickness and diameters is independent of metabolic syndrome in post menopausal women. 100
Aterosclerosi subclinica. influenza dei geni e dell' ambiente 100
Response to Letter to the Editor: "Association of Vitamin D Deficiency With Peripheral Arterial Disease: A Meta-Analysis of Literature Studies" 100
Diagnosis and Screening Strategies for Detection of Familial Hypercholesterolaemia in Children and Adolescents in Italy: A Survey from the LIPIGEN Paediatric Group 96
Exercise for slowing the progression of atherosclerotic process: effects on inflammatory markers 96
Oncology and Cardiac Rehabilitation: An Underrated Relationship 95
Haematological Drugs Affecting Lipid Metabolism and Vascular Health 93
Totale 12.543
Categoria #
all - tutte 45.582
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.582


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022527 7 9 7 6 17 3 3 31 22 78 135 209
2022/2023807 97 57 37 46 96 85 5 81 113 71 93 26
2023/2024774 65 91 53 43 47 84 11 94 21 38 120 107
2024/20254.083 182 146 44 102 82 283 444 277 256 493 1.452 322
2025/20267.679 791 617 806 709 1.271 296 771 394 1.044 450 264 266
2026/2027111 111 0 0 0 0 0 0 0 0 0 0 0
Totale 14.611